The Life Spectrum of Asthma Online: Preventing and Treating Severe Asthma

This module will cover genetic and environmental influences that lead to asthma becoming more severe over time. The mechanistic and clinical characteristics of severe asthma and whether this progression can be prevented and/or reversed will be discussed.

There are four talks in this module. You can view or download the videos or audio along with the presentation handouts from the following pages.  

Talk 1: Severe Asthma: Can it be Prevented or Reversed?
            Sally E. Wenzel, MD FAAAAI

Talk 2: Airway Structural Alterations that Contribute to Severe Asthma
            Reynold A. Panettieri, Jr., MD

Talk 3: Novel Molecular Targets for Severe Asthma
            Harald E. Renz, MD FAAAAI

Talk 4: Differentiating Difficult to Treat from Severe Asthma
            Monica Kraft, MD FAAAAI 

Click here to view faculty responses to audience questions asked during the talks.

The Life Spectrum of Asthma: Online is funded through an educational grant from GlaxoSmithKline.

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training
  • Allied Health providers 

Learning Objectives

Upon completion of this activity, learners should be able to:

  • Define the mechanistic and clinical characteristics of severe asthma
  • Differentiate difficult to treat from severe asthma
Summary
Available credit: 
  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.
Course opens: 
10/03/2016
Course expires: 
10/02/2018
Member cost:
$60.00
Cost:
$75.00
Rating: 
0

Faculty members and disclosures will be listed with each talk.

Moderators
Daniel Rotrosen, MD 
National Institutes of Health/NIAID
Relevant relationships: None

Lewis J. Smith, MD 
Northwestern University
Relevant relationships: None

Planning Committee Disclosures
Thomas B. Casale, MD FAAAAI
University of South Florida
Relevant relationships: Sanofi-Regeneron, Teva, Novartis, Genentech, Boehringer Ingelheim, AstraZeneca (advisory board); Allerquest, Circassia, Capnia (consultant); Parexel (honorarium)

Robert F. Lemanske, Jr., MD FAAAAI
University of Wisconsin 
Relevant relationships: Pharmaxis (research funding) 

CME Committee Reviewers
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR 
Relevant relationships: None

Available Credit

  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.

Accreditation Period

Course opens: 
10/03/2016
Course expires: 
10/02/2018

Price

Member cost:
$60.00
Cost:
$75.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is not supported.